About Yield10 Bioscience (NASDAQ:YTEN)
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company, through its Smart Carbon Grid for Crops and T3 platforms is involved in improving fundamental crop yield through enhanced photosynthetic carbon capture, as well as increased carbon utilization efficiency to increase seed yield. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was founded in 1992 and is headquartered in Woburn, Massachusetts.
Industry, Sector and Symbol
Industry Miscellaneous plastics products
Sub-IndustryN/A
SectorConsumer Staples
SymbolNASDAQ:YTEN
CUSIPN/A
Phone617-583-1700
Debt
Debt-to-Equity Ratio0.08%
Current Ratio6.29%
Quick Ratio6.29%
Price-To-Earnings
Trailing P/E Ratio-0.51
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$940,000.00
Price / Sales17.89
Cash FlowN/A
Price / CashN/A
Book Value$1.48 per share
Price / Book1.14
Profitability
EPS (Most Recent Fiscal Year)($3.29)
Net Income$-9,390,000.00
Net Margins-995.34%
Return on Equity-170.60%
Return on Assets-101.58%
Miscellaneous
Employees20
Outstanding Shares9,970,000
Yield10 Bioscience (NASDAQ:YTEN) Frequently Asked Questions
What is Yield10 Bioscience's stock symbol?
Yield10 Bioscience trades on the NASDAQ under the ticker symbol "YTEN."
When did Yield10 Bioscience's stock split? How did Yield10 Bioscience's stock split work?
Yield10 Bioscience shares reverse split before market open on Tuesday, May 30th 2017. The 1-10 reverse split was announced on Friday, May 26th 2017. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 26th 2017. An investor that had 100 shares of Yield10 Bioscience stock prior to the reverse split would have 10 shares after the split.
How were Yield10 Bioscience's earnings last quarter?
Yield10 Bioscience, Inc. (NASDAQ:YTEN) posted its quarterly earnings data on Thursday, March, 8th. The specialty chemicals company reported ($0.99) EPS for the quarter. The specialty chemicals company had revenue of $0.10 million for the quarter. Yield10 Bioscience had a negative return on equity of 170.60% and a negative net margin of 995.34%. View Yield10 Bioscience's Earnings History.
Who are some of Yield10 Bioscience's key competitors?
Some companies that are related to Yield10 Bioscience include General Agriculture (GELT), Amrep (AXR), Senomyx (SNMX), Royal Hawaiian Orchards (NNUTU), PwrCor (PWCO), TDH (PETZ), Willamette Valley Vineyards (WVVI), MamaMancini's (MMMB), Eastside Distilling (EAST), China New Borun (BORN), Ocean Bio-Chem (OBCI), Glg Life Tech (GLGLF), RiceBran Technologies (RIBT), Big Rock Brewery (BRBMF) and Coffee (JVA).
Who are Yield10 Bioscience's key executives?
Yield10 Bioscience's management team includes the folowing people:
- Dr. Oliver P. Peoples Ph.D., Co-Founder, Pres, CEO & Director (Age 60)
- Dr. Anthony J. Sinskey, Co-Founder & Director (Age 78)
- Dr. Kristi Snell Ph.D., Chief Science Officer & VP - Research (Age 50)
- Ms. Lynne H. Brum, VP - Planning & Communications and Sec. (Age 54)
- Mr. Charles B. Haaser, Chief Accounting Officer, Principal Financial Officer, VP of Fin. & Treasurer (Age 62)
Has Yield10 Bioscience been receiving favorable news coverage?
Press coverage about YTEN stock has trended somewhat positive on Monday, according to Accern Sentiment Analysis. The research group identifies positive and negative media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Yield10 Bioscience earned a news sentiment score of 0.22 on Accern's scale. They also gave news stories about the specialty chemicals company an impact score of 45.94 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future.
How do I buy shares of Yield10 Bioscience?
Shares of YTEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Yield10 Bioscience's stock price today?
One share of YTEN stock can currently be purchased for approximately $1.6865.
How big of a company is Yield10 Bioscience?
Yield10 Bioscience has a market capitalization of $16.80 million and generates $940,000.00 in revenue each year. The specialty chemicals company earns $-9,390,000.00 in net income (profit) each year or ($3.29) on an earnings per share basis. Yield10 Bioscience employs 20 workers across the globe.
How can I contact Yield10 Bioscience?
Yield10 Bioscience's mailing address is 19 PRESIDENTIAL WAY, WOBURN MA, 01801. The specialty chemicals company can be reached via phone at 617-583-1700 or via email at [email protected]
MarketBeat Community Rating for Yield10 Bioscience (YTEN)
MarketBeat's community ratings are surveys of what our community members think about Yield10 Bioscience and other stocks. Vote "Outperform" if you believe YTEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe YTEN will underperform the S&P 500 over the long term. You may vote once every thirty days.
Yield10 Bioscience (NASDAQ:YTEN) SEC Filings
This page is loading this company's SEC Filings. Please wait...
